The number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030. Although oncology clinical trials can be the most complex requiring advanced skills to manage, our clinical team members and medical personnel have world-class experience. So, whether it’s a standard dose-escalation Phase I trial or a complex Phase III study rescue, our team has what it takes to handle it successfully.
We approach every study from the perspective of a community oncology practice – in turn building excellent relationships with our clinical sites.